Professor Stephen Anderton
Group Head of Translational Biology
Steve is Professor of Therapeutic Immunology at the University of Edinburgh, where he is a Theme Leader within MRC/UoE Centre for Inflammation Research and senior investigator in the Centre for MS Research.
VP of Translational Biology
Clare joined Aquila at the point of company creation in 2011, after 13 years working in the global CRO sector (previously Quintiles and Aptuit). Along with company founders and Principal Scientist (Dr Hayley Gooding), Clare has built Aquila into a thriving high growth company that is innovative and responsive to our increasing client requirements. She brings a combination of scientific insight, business acumen and leadership to the Aquila team. Now under the new ownership of Concept Life Sciences (and Spectris) Clare will be instrumental in navigating the team through the transition and beyond.Connect
Dr Louise Welch
Business Development & Marketing Associate
Louise joined Aquila in 2016 in a dual role as our Business Development and Marketing Associate. She has a PhD in immunology from the University of Edinburgh and brings experience of Science Communication and marketing skills to the company. In this role, she has been instrumental in rebranding the company, launching a new website and taking responsibility for the business pipeline. Louise is the first point of contact for Aquila and supports clients through their journey in working with Aquila.Connect